early detection
Viome has adapted its technology to search for the presence of oral squamous cell carcinoma and oropharyngeal cancer in users’ saliva samples.
This report represents early findings from the TemPredict study, which has a goal to develop an algorithm that predicts the onset of symptoms such as fever, cough and fatigue.
Newly published data from Scripps' DETECT study included data from 30,529 device owners, although only 333 of those who were symptomatic also provided their COVID-19 testing results.
With the research gathered in its study, Fitbit hopes to create an algorithm that can detect diseases such as COVID-19 before symptoms start using physiological signs.